Specifications include, but are not limited to: The Minnesota Department of Human Services, through its Behavioral Health, Housing, and Deaf & Hard of Hearing Services Administration Division (STATE), is seeking Proposals from qualified Responders to provide evidence based Opioid Use Disorder (OUD) services in these categories: 1. School based prevention, 2. Expand and enhance access to Medication for Opioid Use Disorder (MOUD) for American Indian population, 3. Extension for Community Healthcare Outcomes (ECHO) with an American Indian focused curriculum, and 4. Physician consultation for statewide planning. School-based prevention – $765,000.00 is dedicated to this category. Deliver school-based prevention strategies and curriculum to reduce opioid abuse and misuse among youth 12-19 years old. These services should be focused on youth with a goal of reducing the future use of drugs that lead to abuse and addiction to opioid based substances, including prescription drugs and fentanyl analogs. Prevention strategies should be designed to address intervening variables and risk factors among the focused population(s) and implementation of Evidence-Based Practices (EBP) in prevention and raise awareness regarding evidence-based, culturally responsive clinical interventions to address, develop, and foster protective factors. Expand and enhance access to medication for opioid use disorder (MOUD) for American Indians- $1,500,000 is dedicated to this category. Responders in this category shall provide access to services that are culturally responsive to the American Indian community and align with federal Culturally and Linguistically Appropriate Health Services (CLAS) standards. Culturally responsive or culturally specific must indicate how National CLAS Standards are implemented and how the programming and staff represent the population they are serving. Services may include but not limited to: Office Based Opioid Treatment – High quality, well-coordinated MOUD is an essential part of treatment for OUD. Office-Based Opioid Treatment (OBOT) providers (i.e., providers who are prescribing MAT outside of a Rule 31 Opioid Treatment Program) are a cornerstone of effective MOUD, and the supply of OBOT practices does not yet meet the need throughout Minnesota. Responders must demonstrate a willingness to establish a new or grow an existing practice to treat patients with OUD, including their commitment for expanding the number of Drug Enforcement Administration (DEA)-waivered clinicians. Responders should indicate how they will ensure practitioners eligible to obtain a Drug Addiction Treatment Act (DATA) waiver employed by their organization receives the waiver. New or expanded OBOT/MAT practices being designed with this grant support should conform to the American Society of Addiction Medicine (ASAM) National Practice Guideline for Treatment of Opioid Use Disorder. Responders must describe the program they intend to initiate or expand, including how they will support access to multidisciplinary OUD treatments and social supports within their program.
